Non-AT1-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil
Authors:
Open Access
- 1 June 2001
- journal article
- other
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 2 (2) , 103-106
Abstract
Previous studies have shown that angiotensin II (Ang II), by mediating rapid recruitment of collateral circulation, has a protective effect in the setting of acute ischaemia. In an experimental model of acute cerebral ischaemia in the gerbil, Fernandez et al. have reported that the mechanism of the protective effect of Ang II is blood pressure (BP)-independent,1 and that the AT 1-receptor antagonist, losartan, but not the ACE inhibitor (ACE-I), enalapril, decreases mortality following unilateral carotid artery ligation. 2 The aim of this study was to examine the reproducibility of the respective effects of losartan and enalapril, and to verify that these differential effects are drug class-related. Acute cerebral ischaemia was induced in anaesthetised gerbils by unilateral carotid ligation. The effect of pretreatment with two different ACE-I (enalapril and lisinopril), and two different AT 1-receptor antagonists (losartan and candesartan), administered orally or intravenously, on mortality were compared. Kaplan-Meier survival curves at day three were analysed by a log-rank test. Pretreatment with both enalapril and lisinopril significantly decreased survival at day three compared with controls, while the AT1-receptor antagonists losartan and candesartan, despite similarly lowering BP, did not increase mortality. Coadministration of losartan and enalapril increased mortality to the same extent as enalapril alone. This study confirms that Ang II contributes to protective mechanisms against acute cerebral ischaemia through non AT1-receptor-mediated, BP-independent effects.Keywords
This publication has 9 references indexed in Scilit:
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 1999
- Enalapril Prevents Imminent and Reduces Manifest Cerebral Edema in Stroke-Prone Hypertensive RatsStroke, 1998
- Angiotensin AT2 Receptor Stimulation Increases Survival in Gerbils with Abrupt Unilateral Carotid LigationJournal of Cardiovascular Pharmacology, 1994
- Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.BMJ, 1992
- Differences in Mortality Rate between Abrupt and Progressive Carotid Ligation in the Gerbil: Role of Endogenous Angiotensin IIJournal of Cerebral Blood Flow & Metabolism, 1988
- DOES ANGIOTENSIN-II PROTECT AGAINST STROKES?The Lancet, 1986
- Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation.Stroke, 1986
- MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.BMJ, 1985
- On the relationship of brain vasculature to production of neurological deficit and morphological changes following acute unilateral common carotid artery ligation in gerbilsJournal of the Neurological Sciences, 1975